EPC — Edgewell Personal Care Company

Is EPC overbought or oversold? Here is the current MarketMoodz read.

Consumer Defensive · Household & Personal Products

Overbought As of August 19, 2026

Edgewell Personal Care Company (EPC) currently reads Overbought on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The Consumer Defensive name (Household & Personal Products) last closed at $28.74. The rating moved from Neutral to Overbought on August 13, 2026.

See all overbought Consumer Defensive stocks →

AI analysis

Edgewell Personal Care Company (EPC) is a mid-cap personal-care manufacturer with defensive brand positions and predictable cash flows but limited organic growth momentum. Near-term performance will be driven by execution on margin initiatives, the company’s ability to manage input and reformulation costs, and retail channel dynamics. With little social or macro-driven volatility in the immediate market window, share movement should track company-specific earnings commentary and any updates on cost savings, new-product rollouts, or retailer relationships. Key risks include execution shortfalls, commodity inflation, and regulatory-driven reformulation costs; upside would require steady margin recovery and modest top-line stabilization or successful premiumization initiatives.

Key factors

  • Established branded portfolio with consistent shelf presence across mass and specialty channels, providing defensive cash flow in softer consumption periods
  • Operational improvement initiatives and margin-management programs that can partially offset input-cost pressure if executed effectively
  • Exposure to retail partners and mass channels means demand is sensitive to retailer promotions and inventory cycles
  • Ingredient reformulation and clean-label trends create both cost/headline risk and an opportunity to premiumize products if investment is targeted
  • Macro/market backdrop in the short window is neutral, leaving near-term moves driven more by company-specific news than broad flows
  • Limited visible social/research momentum in the recent window, so market reaction will hinge on earnings commentary and execution updates

Risks

  • Execution risk on cost-reduction programs and new-product innovation; missed targets could weigh on margins and cash generation
  • Raw material and input-cost volatility (commodities, packaging) that can compress margins if price passthrough is limited
  • High exposure to a few large retail customers; adverse channel terms or inventory destocking would hit revenue and working capital
  • Regulatory/consumer scrutiny on ingredients (clean-label/GRAS developments) could force reformulation costs or limit SKUs
  • Slower-than-expected top-line growth in a mature personal-care category, limiting upside absent meaningful market-share gains
  • Currency and broader macro weakness that reduces discretionary spend on premium personal-care items

Latest MarketMoodz coverage

See today's live rating, score and targets

Members see the live hourly rating for EPC — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.